Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Gérard Lledo"'
Autor:
Christelle De La Fouchardiere, Astrid Lièvre, Emmanuelle Samalin, Gérard Lledo, Thierry André, Jean-Marc Phelip, S. Benoist
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2020, 107 (9), pp.881-895. ⟨10.1016/j.bulcan.2020.04.017⟩
Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (9), pp.881-895. ⟨10.1016/j.bulcan.2020.04.017⟩
Bulletin du Cancer, 2020, 107 (9), pp.881-895. ⟨10.1016/j.bulcan.2020.04.017⟩
Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (9), pp.881-895. ⟨10.1016/j.bulcan.2020.04.017⟩
National audience; La mutation BRAFV600E, observée chez 8 % des cancers colorectaux (CCR), confère un phénotype particulier et un mauvais pronostic aux CCR, que ce soit au stade localisé ou métastatique. Les CCR BRAF mutés sont préférentielle
Autor:
K. Gnep, Véronique Vendrely, Emilie Barbier, Xavier Mirabel, Claire Lemanski, Laetitia Dahan, Farid El Hajbi, for Ffcd Debiri investigators, Didier Cowen, Thomas Aparicio, Côme Lepage, Vincent Mammar, Sylvain Manfredi, Eric Terrebonne, Gérard Lledo
Publikováno v:
Radiotherapy and Oncology. 140:84-89
Background and purpose Standard treatment of epidermoid anal cancer is 5-fluorouracil (5FU) and mitomycin C (MMC) based chemoradiotherapy (CRT). This phase I study aims to evaluate the addition of panitumumab (Pmab) to CRT and to determine the maximu
Autor:
Astrid, Lièvre, Christelle, de la Fouchardière, Emmanuelle, Samalin, Stéphane, Benoist, Jean-Marc, Phelip, Thierry, André, Gérard, Lledo
Publikováno v:
Bulletin du cancer. 107(9)
The BRAF
Publikováno v:
Bulletin du Cancer. 105:408-414
Resume L’allongement des durees de survie dans le traitement du cancer colorectal metastatique impose des strategies therapeutiques comprenant des periodes de traitement d’entretien, voire des pauses therapeutiques completes. Plusieurs essais ran
Autor:
Romain Coriat, Franck Bonnetain, Gérard Lledo, Stéphane Obled, Marion Selosse, Mariella de Bausset, Pascal Hammel
Publikováno v:
Bulletin du Cancer. 104:321-331
Data in the literature regarding the care pathway of pancreatic cancer patients are limited. The objective of the REPERE survey was to identify and describe the initial stages of the care pathway of pancreatic patients in the metastatic phase. From M
Autor:
Benoist Chibaudel, Frédéric Di Fiore, Gérard Lledo, Astrid Pozet, Pascal Artru, Nicolas Jovenin, Olivier Dupuis, Valérie Blondin, Mohamed Attia, Laurent Mineur, Aimery de Gramont, Laetitia Dahan, Menouar Samir Abdiche, Franck Bonnetain, Florence Huguet, Marie-Pierre Galais
Publikováno v:
European Journal of Cancer. 56:115-121
Background To determine efficacy and toxicity of radiation therapy combined with oxaliplatin, 5-fluorouracil, and folinic acid (FOLFOX) and cetuximab in patients with locally advanced oesophageal cancer. Patients and methods Patients with stage III o
Autor:
Gérard Lledo, Julien Taieb, Olivier Pellerin, Jérôme Desramé, Simon Pernot, François Mithieux, Julien Marsot, Philippe Chalabreysse, Pascal Artru, Emmanuel Watkin
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 39:e73-e77
Summary Introduction Most liver metastases from colorectal cancer (CRC) are unresectable at diagnosis. Systemic chemotherapy allows secondary surgical resection in 10 to 20% of patients. Hepatic intra-arterial treatments could enhance response and re
Autor:
Jean-François Ramée, Christophe Tournigand, Thierry André, Paul Mésange, Franck Bonnetain, Werner Scheithauer, Benoist Chibaudel, Yves Rinaldi, Olivier Dupuis, May Mabro, Annette K. Larsen, Gérard Lledo, Christophe Louvet, Dewi Vernerey, B. Samson, Nathalie Aucoin, Jérôme Dauba, Aimery de Gramont, Frédéric Viret, Jean Latreille, Nicole Tubiana-Mathieu
Publikováno v:
The Lancet Oncology. 16:1493-1505
Summary Background The combination of an anti-VEGF or an anti-EGFR-targeted monoclonal antibody with chemotherapy has shown clinical activity in patients with metastatic colorectal cancer. However, combining both anti-VEGF and anti-EGFR antibodies wi
Autor:
Thomas Walter, Stephanie Morgant, Arnaud Pasquer, Catherine Brezault, Romain Coriat, Nelson Lourenco, Jean-Marc Gornet, Alexandre Rouquette, Gérard Lledo, Ammar Oudjit, Pascal Artru
Publikováno v:
Cancer Management and Research
Stéphanie Morgant,1 Pascal Artru,2 Ammar Oudjit,3 Nelson Lourenco,4 Arnaud Pasquer,5 Thomas Walter,6 Jean-Marc Gornet,4 Alexandre Rouquette,7 Gérard Lledo,2 Catherine Brezault,1 Romain Coriat1 1Gastroenterology and Digestive Oncology Unit, Cochin T
Autor:
Benoist Chibaudel, Valérie Lebrun Ly, Gael Deplanque, Aimery de Gramont, Jérôme Desramé, Cedric Lecaille, Thierry André, Christophe Tournigand, Jérôme Dauba, Jean-Baptiste Bachet, Olivier Dubreuil, Annette K. Larsen, Franck Bonnetain, Christophe Louvet, Dominique Auby, Nabil Baba Hamed, Marie Line Garcia, Gérard Lledo, Aurélia Meurisse, Annemilaï Tijeras‑Raballand
Publikováno v:
International journal of oncology. 54(4)
Aflibercept in combination with 5‑fluorouracil (5‑FU)/irinotecan improves overall survival in the second‑line therapy of patients with metastatic colorectal cancer (mCRC). In this study, we evaluated the effects of aflibercept in first‑line t